ProPhase Labs PRPH
OTC PRPH
$0.01 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

ProPhase Labs (PRPH) Non-Current Deferred Tax Liability (2022)

Analysis

ProPhase Labs (PRPH) Non-Current Deferred Tax Liability (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 ProPhase Labs 155,925.56 -390,074.44 226,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 224,000.00
Mar 31, 2022 443,000.00
API Access

ProPhase Labs Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=PRPH&period=max&api_key=YOUR_API_KEY